» Articles » PMID: 19535633

STAT6 Activation Confers Upon T Helper Cells Resistance to Suppression by Regulatory T Cells

Overview
Journal J Immunol
Date 2009 Jun 19
PMID 19535633
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have highlighted characteristics of T regulatory cells (Tregs) that underlie their suppressive function. However, mechanisms that override their suppressive function in the context of an adaptive immune response are not well understood. In the lungs of mice undergoing allergic inflammation, appreciable numbers of Tregs were identified that possessed suppressive function when assayed ex vivo. We investigated whether the Th2-promoting cytokine IL-4 played a permissive role that superseded Treg function, thereby allowing the development of allergic inflammation. IL-4 signaling via the IL-4Ralpha-STAT6 axis was required to maintain Foxp3 expression in Tregs and promote their proliferation. However, the results of both in vivo experiments involving adoptive transfer of Tregs into Ag-sensitized vs naive animals and in vitro suppression assays performed with or without exogenous IL-4 showed the ability of IL-4 to compromise Treg-mediated suppression. Use of retrovirally expressed, constitutively active STAT6 revealed that the underlying mechanism was not IL-4-mediated dysfunction of Tregs but involved the resistance of Th cells to Treg-mediated suppression that would permit the development of an adaptive immune response. Our data suggest that infectious tolerance, mediated by membrane-bound TGF-beta expressed by Tregs, is compromised by the competing effects of IL4-induced signaling in naive CD4(+) Th cells.

Citing Articles

The divergent outcome of IL-4Rα signalling on Foxp3 T regulatory cells in listeriosis and tuberculosis.

Chia J, Rousseau R, Ozturk M, Poswayo S, Lucas R, Brombacher F Front Immunol. 2024; 15:1427055.

PMID: 39483462 PMC: 11524857. DOI: 10.3389/fimmu.2024.1427055.


Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis.

Llano-Leon M, Martinez-Enriquez L, Rodriguez-Bohorquez O, Velandia-Vargas E, Lalinde-Ruiz N, Villota-Alava M PLoS One. 2023; 18(4):e0277714.

PMID: 37104271 PMC: 10138237. DOI: 10.1371/journal.pone.0277714.


Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6.

Baris S, Benamar M, Chen Q, Catak M, Martinez-Blanco M, Wang M J Allergy Clin Immunol. 2023; 152(1):182-194.e7.

PMID: 36758835 PMC: 10330134. DOI: 10.1016/j.jaci.2023.01.023.


Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD Rhapsody VDJ CDR3 Assay.

Okamura T, Hamaguchi M, Tominaga H, Kitagawa N, Hashimoto Y, Majima S Cells. 2022; 11(10).

PMID: 35626661 PMC: 9139223. DOI: 10.3390/cells11101623.


Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy.

Raimondo T, Mooney D Sci Adv. 2021; 7(26).

PMID: 34162554 PMC: 8221619. DOI: 10.1126/sciadv.abh3693.


References
1.
Vignali D, Collison L, Workman C . How regulatory T cells work. Nat Rev Immunol. 2008; 8(7):523-32. PMC: 2665249. DOI: 10.1038/nri2343. View

2.
Curotto de Lafaille M, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille J . Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity. 2008; 29(1):114-26. DOI: 10.1016/j.immuni.2008.05.010. View

3.
Chen C, Seguin-Devaux C, Burke N, Oriss T, Watkins S, Clipstone N . Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J Exp Med. 2003; 197(12):1689-99. PMC: 2193945. DOI: 10.1084/jem.20021170. View

4.
Zheng S, Wang J, Wang P, Gray J, Horwitz D . IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. 2007; 178(4):2018-27. DOI: 10.4049/jimmunol.178.4.2018. View

5.
Mohrs M, Lacy D, Locksley R . Stat signals release activated naive Th cells from an anergic checkpoint. J Immunol. 2003; 170(4):1870-6. DOI: 10.4049/jimmunol.170.4.1870. View